Literature DB >> 19329559

What we know: findings that every theory of schizophrenia should explain.

Angus W MacDonald1, S Charles Schulz.   

Abstract

The article summarizes the process used to distill schizophrenia science into 22 facts. These facts consist of 6 basic facts, 3 etiological facts, 6 pharmacological and treatment facts, 5 pathology facts, and 2 behavioral facts that were critically reviewed by the scholarly community through a special initiative in cooperation with the Schizophrenia Research Forum. A subset of 10 of these facts was selected to form a common set of findings to be explained from the different theoretical perspectives included in this special section of Schizophrenia Bulletin. The rationale for this exercise is to distinguish more precisely the areas of agreement and disagreement between theories of schizophrenia and to highlight where more thought and data can make the greatest impact for understanding this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329559      PMCID: PMC2669587          DOI: 10.1093/schbul/sbp017

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  102 in total

1.  Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia.

Authors:  J A Badner; E S Gershon
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

Review 2.  Schizophrenia and urbanicity: a major environmental influence--conditional on genetic risk.

Authors:  Lydia Krabbendam; Jim van Os
Journal:  Schizophr Bull       Date:  2005-09-08       Impact factor: 9.306

Review 3.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 4.  Cognitive remediation and vocational rehabilitation for schizophrenia.

Authors:  Bruce E Wexler; Morris D Bell
Journal:  Schizophr Bull       Date:  2005-08-03       Impact factor: 9.306

5.  Mismatch negativity in schizophrenia: a meta-analysis.

Authors:  Daniel Umbricht; Sanya Krljes
Journal:  Schizophr Res       Date:  2005-01-23       Impact factor: 4.939

6.  Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.

Authors:  Wiepke Cahn; Hilleke E Hulshoff Pol; Elleke B T E Lems; Neeltje E M van Haren; Hugo G Schnack; Jeroen A van der Linden; Patricia F Schothorst; Herman van Engeland; René S Kahn
Journal:  Arch Gen Psychiatry       Date:  2002-11

Review 7.  Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group.

Authors:  R Howard; P V Rabins; M V Seeman; D V Jeste
Journal:  Am J Psychiatry       Date:  2000-02       Impact factor: 18.112

Review 8.  Sex differences in schizophrenia, a review of the literature.

Authors:  A Leung; P Chue
Journal:  Acta Psychiatr Scand Suppl       Date:  2000

9.  Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9.

Authors:  Lynn D Selemon; Jasna Mrzljak; Joel E Kleinman; Mary M Herman; Patricia S Goldman-Rakic
Journal:  Arch Gen Psychiatry       Date:  2003-01

Review 10.  A systematic review of the prevalence of schizophrenia.

Authors:  Sukanta Saha; David Chant; Joy Welham; John McGrath
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

View more
  50 in total

Review 1.  Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials.

Authors:  Kazuto Oya; Yuki Matsuda; Shinji Matsunaga; Taro Kishi; Nakao Iwata
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-25       Impact factor: 5.270

2.  Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes.

Authors:  Alexis C Edwards; Tim B Bigdeli; Anna R Docherty; Silviu Bacanu; Donghyung Lee; Teresa R de Candia; Arden Moscati; Dawn L Thiselton; Brion S Maher; Brandon K Wormley; Dermot Walsh; Francis A O'Neill; Kenneth S Kendler; Brien P Riley; Ayman H Fanous
Journal:  Schizophr Bull       Date:  2015-08-27       Impact factor: 9.306

3.  Variable global dysconnectivity and individual differences in schizophrenia.

Authors:  Michael W Cole; Alan Anticevic; Grega Repovs; Deanna Barch
Journal:  Biol Psychiatry       Date:  2011-04-15       Impact factor: 13.382

Review 4.  Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.

Authors:  Matcheri S Keshavan; Henry A Nasrallah; Rajiv Tandon
Journal:  Schizophr Res       Date:  2011-02-12       Impact factor: 4.939

Review 5.  Inefficient neural system stabilization: a theory of spontaneous resolutions and recurrent relapses in psychosis

Authors:  Lena Palaniyappan
Journal:  J Psychiatry Neurosci       Date:  2019-11-01       Impact factor: 6.186

Review 6.  Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings.

Authors:  Benjamin K Brent; Heidi W Thermenos; Matcheri S Keshavan; Larry J Seidman
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2013-07-23

7.  Cannabis use disorders in schizophrenia: effects on cognition and symptoms.

Authors:  Pamela DeRosse; Alyson Kaplan; Katherine E Burdick; Todd Lencz; Anil K Malhotra
Journal:  Schizophr Res       Date:  2010-05-18       Impact factor: 4.939

8.  Stress Sensitivity and Psychotic Experiences in 39 Low- and Middle-Income Countries.

Authors:  Jordan E DeVylder; Ai Koyanagi; Jay Unick; Hans Oh; Boyoung Nam; Andrew Stickley
Journal:  Schizophr Bull       Date:  2016-04-24       Impact factor: 9.306

9.  The link between schizophrenia and hypothyroidism: a population-based study.

Authors:  Kassem Sharif; Shmuel Tiosano; Abdulla Watad; Doron Comaneshter; Arnon D Cohen; Yehuda Shoenfeld; Howard Amital
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

10.  A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis.

Authors:  Cristina Cacciotti-Saija; Robyn Langdon; Philip B Ward; Ian B Hickie; Elizabeth M Scott; Sharon L Naismith; Loretta Moore; Gail A Alvares; Marie Antoinette Redoblado Hodge; Adam J Guastella
Journal:  Schizophr Bull       Date:  2014-06-23       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.